Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 2
1995 1
1996 3
1997 1
1998 2
1999 5
2000 2
2005 6
2006 2
2007 4
2008 4
2009 2
2010 2
2011 5
2012 5
2013 6
2014 5
2015 5
2016 3
2018 2
2019 3
2020 9
2021 10
2022 9
2023 7
2024 10
2025 7
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial.
Kitamura H, Tsukamoto T, Kakehi Y, Mizusawa J, Shibata T, Sasaki K, Tanikawa T, Hashine K, Fujimoto K, Masumori N, Kobayashi T, Habuchi T, Kimura T, Sugimoto M, Takahashi A, Adachi H, Matsui Y, Hatakeyama S, Ito A, Eto M, Nishiyama H; Urologic Oncology Study Group of the Japan Clinical Oncology Group. Kitamura H, et al. Among authors: hashine k. Eur Urol. 2026 May;89(5):437-445. doi: 10.1016/j.eururo.2026.01.008. Epub 2026 Jan 21. Eur Urol. 2026. PMID: 41571573 Free article. Clinical Trial.
Comprehensive analysis of oncological outcomes of radical cystectomy for non-muscle invasive bladder cancer.
Sano T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kobayashi T; Japan Urological Oncology Group. Sano T, et al. Among authors: hashine k. Sci Rep. 2026 Apr 5;16(1):16338. doi: 10.1038/s41598-026-46649-w. Sci Rep. 2026. PMID: 41936674 Free PMC article.
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab.
Tanegashima T, Shiota M, Akamatsu S, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tokunaga S, Eto M; SNiP‐RCC investigators. Tanegashima T, et al. Among authors: hashine k. Cancer Sci. 2025 Dec;116(12):3300-3308. doi: 10.1111/cas.70204. Epub 2025 Sep 24. Cancer Sci. 2025. PMID: 40991840 Free PMC article.
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort.
Saito R, Taoka R, Miki J, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kinoshita H; Japan Urological Oncology Group. Saito R, et al. Among authors: hashine k. Int J Clin Oncol. 2025 Oct;30(10):2106-2117. doi: 10.1007/s10147-025-02833-y. Epub 2025 Jul 21. Int J Clin Oncol. 2025. PMID: 40690100
A case of EBV-associated adrenal leiomyoma.
Takemoto T, Kiriyama I, Sugawara Y, Abe C, Teramoto N, Hashine K, Yoshida I, Asagi A. Takemoto T, et al. Among authors: hashine k. Radiol Case Rep. 2024 Mar 16;19(6):2224-2229. doi: 10.1016/j.radcr.2024.02.044. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38523717 Free PMC article.
Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan.
Kawai T, Miki J, Taoka R, Saito R, Fukuokaya W, Matsui Y, Fujii Y, Hatakeyama S, Kawahara T, Matsuda A, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Nakayama M, Matsumoto T, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Kobayashi K, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kume H; Japan Urological Oncology Group. Kawai T, et al. Among authors: hashine k. Jpn J Clin Oncol. 2026 Apr 9;56(4):475-483. doi: 10.1093/jjco/hyaf218. Jpn J Clin Oncol. 2026. PMID: 41543041
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan.
Yamada S, Sato M, Osawa T, Harabayashi T, Miki J, Kobayashi T, Hashine K, Kawashima A, Matsumoto T, Mochizuki T, Taoka R, Urabe F, Tatarano S, Sawada A, Kojima T, Takahashi A, Yokomizo A, Suekane S, Hashimoto K, Hashimoto Y, Yatsuda J, Morita K, Kobayashi K, Satake Y, Sazawa A, Matsui Y, Ito YM, Shimizu S, Fukuhara S, Nishiyama H, Kitamura H, Shinohara N; Japanese Urological Oncology Group. Yamada S, et al. Among authors: hashine k. Cancer Sci. 2026 Mar;117(3):739-748. doi: 10.1111/cas.70289. Epub 2026 Jan 4. Cancer Sci. 2026. PMID: 41486068 Free PMC article.
Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study.
Sazuka T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Sawada A, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ichikawa T; Japan Urological Oncology Group. Sazuka T, et al. Among authors: hashine k. Int J Clin Oncol. 2025 Jul;30(7):1417-1425. doi: 10.1007/s10147-025-02778-2. Epub 2025 May 10. Int J Clin Oncol. 2025. PMID: 40347426
Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial.
Ito A, Arai Y, Kakehi Y, Yokoyama M, Sasaki K, Uemura M, Takahashi A, Nishimura K, Kawahara T, Masuda H, Yoshimura K, Kobayashi T, Eto M, Igawa T, Nishiyama N, Mochizuki T, Yokomizo A, Miyake M, Ichikawa T, Hashine K, Sato T, Sugimoto M, Nishiyama H, Kitamura H; Urologic Oncology Study Group of the Japan Clinical Oncology Group. Ito A, et al. Among authors: hashine k. Lancet Oncol. 2026 Aug;27(8):973-982. doi: 10.1016/S1470-2045(26)00130-0. Epub 2026 Jul 11. Lancet Oncol. 2026. PMID: 42435772
120 results